Glaukos GKOS

HealthcareMarket cap $4B1 connection

Glaukos makes minimally invasive glaucoma surgery (MIGS) devices - tiny implants inserted during cataract surgery to reduce intraocular pressure. Its iStent is the world's smallest FDA-approved implant. As the baby boom population ages and glaucoma prevalence rises, MIGS procedures are growing 15%+ annually as an alternative to eye drops.

Explore Glaukos on the interactive map Relationship timeline Find a path to another company

Partners 1

Strategic partnerships, joint products and alliances

Abbott LabsHealthcare · $200BGlaukos competes with Abbott in MIGS ophthalmic space

Other Healthcare companies

Eli Lilly UnitedHealth Novo Nordisk Johnson & Johnson AbbVie Merck AstraZeneca Thermo Fisher Novartis Abbott Labs

Embed this on your site

Show Glaukos's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=GKOS" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Glaukos on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.